7 views
# Cardiovascular disease how many die # :::warning Constant high levels of stress can disturb the blood flow and blood pressure and can damage vessels, and you may experience dizziness, extreme fatigue, or body aches with no wish to get out of bed. This stress-induced fatigue can make your blood pressure high and needs to be monitored. ::: [![](https://cardio-balance-ph.store-best.net/img/7.jpg)](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## The prevalence of risk factors for cardiovascular diseases ## <div class="alert alert-info" role="alert"> Minsan lang na biglaang pagtaas ng presyon o bahagyang mataas na resulta ay hindi palaging nangangailangan ng agarang pag-inom ng tableta. Lahat ng rekomendasyon ng mga espesyalista at ang mga magagamit na paraan ng pag-iwas ay mukhang simple lang, pero sa aktwal na buhay, ang maingat na pag-aalaga sa kalusugan ng dugo at sistema ng puso ay nakakaiwas sa biglaan at sobrang hindi kanais-nais na pagtaas ng presyon. </div> Cardiovascular disease: mortality and social impact Cardiovascular disease (CVD) is the leading cause of death, and thus have a significant health political significance. According to data from the world health organization (WHO) die each year, approximately 17.9 million people to the consequences of cardiovascular disease, which corresponds to approximately 32% of all deaths worldwide. In Europe, a similar pattern: heart disease for more than 45% of the deaths. In Germany, more than 300000 fatalities is estimated that every year on cardiovascular disease. This is especially to the following conditions: Coronary heart disease (CHD) is the most common cause of death within the group of CVD. Stroke: A more significant cause of death and long-term disabilities. Heart failure is A result of various heart diseases, which is associated with a high mortality rate. Arrhythmias and other heart rhythm disorders: Can lead to sudden cardiac death. Demographic and risk factors The mortality due to cardiovascular disease varies by age, gender and socio-economic factors. Elderly people in particular are affected: About 75% of CVD deceased persons older than 70 years. Men have compared to women in the younger age groups have a higher mortality rate, while the differences in advanced age decrease. Among the most important modifiable risk factors: High Blood Pressure (Hypertension), elevated cholesterol levels (Dyslipid a mie), Diabetes mellitus, Smoking Overweight and obesity, lack of physical activity, unhealthy diet. Trends and prevention measures In spite of the high Mortality in the last decades in many industrialized countries could be observed rates, a decrease in the CVD-associated mortality. This is mainly due to: Advances in the medical treatment (e.g., early revascularisation for myocardial infarction), more effective prevention strategies and awareness campaigns, Reduction of risk factors (e.g., drop in the Smoking rate) due to the. At the same time, the burden of CVD in Emerging and developing countries, which is a global priority in health care policy is on the rise. Conclusion Cardiovascular diseases cause worldwide each year, and nearly 18 million deaths. The implementation of prevention programs, early diagnosis and adequate treatment are crucial to reduce this number in the future and to improve the quality of life and expectations of the population. > Cardio Balance is an all-natural formula designed to act on the root cause of high blood pressure and fatal cardiovascular diseases and strokes. It's a zero-risk range for men and women of all ages. The natural ingredients-rich nutrient profile helps reduce blood cholesterol levels and boost blood circulation function, digestive system, and overall health. ![](https://cardio-balance-ph.store-best.net/img/go2.png) <a href="http://diamondmelle.com/includes/multimedia/cmsfiles/side-effects-of-medication-for-high-blood-pressure.xml">Presyong pang-promosyon</a> <a href="http://g-house.com.tw/userfiles/2325-the-pressure-in-hypertension.xml">Cardiovascular disease how many die</a> ## What tablets from Smoking can be high blood pressure ## What Smoking cessation preparations are suitable for people with high blood pressure? High blood pressure (arterial hypertension) represents a major contra-indication or restriction in the selection of drugs for Smoking cessation. Because nicotine increases the blood pressure values and blood vessels narrowed, must be weighed in patients with existing hypertension particularly carefully, what are the treatment options in question. 1. Nicotine replacement therapy (NRT) Products for nicotine replacement therapy such as patches, gum, lozenges, nasal sprays or inhalers deliver a controlled low levels of nicotine without the other harmful substances in the cigarette smoke to be incorporated. Advantages: The NRT reduces withdrawal symptoms and allows for a gradual phase-out of nicotine addiction. Concerns in hypertension: Since nicotine itself acts increasing blood pressure, can be applied to the NRT in the case of uncontrolled hypertension, or recent history of heart attack/stroke with caution. Recommendation: In case of a stable blood pressure, and medical Supervision is admitted to the NRT in the rule. The dose should be low and gradually reduced. 2. Bupropion (Antidepressant) Bupropion acts as an inhibitor of the reuptake process of dopamine and norepinephrine, thus reducing the Craving for nicotine. Counter display in hypertension: Bupropion may increase the blood pressure and is therefore in the case of untreated or poorly controlled hypertension is not recommended. Criteria for use: use Only with stable blood pressure, and after careful consideration of risk and Benefit in consideration can be drawn. Regular blood pressure checks are obligatory. 3. Varenicline (Champix®) Varenicline binds to the nicotinic acetylcholine receptors in the brain and has a double effect: It reduces the withdrawal symptoms and reduces the enjoyment of Smoking. Study location: Clinical studies show that varenicline in patients with hypertension, in General, well tolerated, if the blood pressure medication is well set. Observation duty: Nevertheless, patients should be periodically during therapy the blood pressure measure, because sometimes the blood pressure-increasing effects were observed. Summary and recommendations For smokers with hypertension, the following options are available, but always an individual medical evaluation is required: With a stable, well-adjusted blood pressure: Varenicline (as may be the most effective Option) Nicotine replacement therapy with continuous blood pressure monitoring In the case of uncontrolled hypertension: Primarily non-pharmacological measures: behavioural therapy, counselling, self-help groups Drugs drag only after optimization of blood pressure therapy considered Absolute Exclusions: Bupropion in the case of poorly controlled hypertension NRT immediately after a heart attack or stroke Conclusion Smoking cessation in hypertension is possible and useful, however, requires a close cooperation between the Patient and the doctor. The choice of the drug depends on the individual blood pressure control, the General state of health and the Presence of other risk factors. A combined treatment of medication and psychosocial counselling shows the highest success rates. <a href="http://haciogullari.com/depo/sayfaresim/drugs-against-hypertension-without-side-effects-6267.xml">The prevalence of risk factors for cardiovascular diseases</a> ** Cardiovascular disease how many die **. The prevalence of risk factors for cardiovascular diseases Cardiovascular disease (CVD) is one of the main causes of morbidity and mortality. The identification and quantification of risk factors is of crucial importance for the development of effective prevention strategies. In this contribution, the current prevalence examines important risk factors for CVD in the population. To the well-known modifiable risk factors include: Hypertension (blood pressure≥140/90 mmHg), Hyperlipidemia (elevated levels of LDL‑cholesterol and triglycerides), Diabetes mellitus type 2, Tobacco, Overweight and obesity (BMI≥25 kg/m 2 or ≥30 kg/m 2 ), physical inactivity, unhealthy diet (high, high salt, sugar and saturated fatty acids consumption). In addition to these factors, non-modifiable factors play a role, including: Age (the risk increases significantly from the age of 45. Age in men, and from the age of 55. Year in women), Gender (men are generally affected earlier and more frequently), family history of early onset of cardiovascular diseases. Epidemiological Data According to recent studies, the prevalence of hypertension is located in industrialized countries around 30,0–40,0% of the adult population. Hyperlipidemias are at approx. 25,0–35,0% undetectable. The proportion of persons with Diabetes mellitus type 2 is in many European countries an average of 8,0–10,0%. The use of tobacco as a major risk factor shows in Germany, there is a prevalence of approximately 23,0% of men and 18.0% in women. Overweight and obesity are widespread in the German population, Over 50.0% of the men and 35.0% of women have a BMI ≥25 kg/m 2 on. Physical inactivity is identified as a risk factor in approximately 40.0% of the population, with regional and socio-economic differences. An unhealthy diet, characterized by high salt and sugar content, contributes to the development of hypertension and Metabolic syndrome. Synergistic Effects Particularly problematic is the accumulation of multiple risk factors in the case of a Person (a risk factor Clustering) is. For example, studies show that patients with simultaneous presence of hypertension, Obesity and Diabetes have a significantly increased risk of heart attack and stroke – to a 5‑ to 7‑fold increase compared to the population without these factors. Conclusions The high prevalence of modifiable risk factors highlights the need for broad-based prevention measures: health policy measures for the reduction of salt and sugar in the finished products, Promoting physical activity in schools and the workplace, Awareness-raising campaigns about tobacco waiver and healthy diet, systematic blood pressure and cholesterol Screening programs, particularly in high-risk groups. A consistent fight against these risk factors can reduce the individual and collective risk for cardiovascular disease is significantly and the quality of life and life expectancy of the population. Would you like me to make a certain section in more detail or to request further information/source of information complementary? - [x] <a href="http://first-produce.com/of-hypertension-in-diabetes-mellitus-90.xml">The prevalence of risk factors for cardiovascular diseases</a> - [x] <a href="https://doc.spiegie.de/s/RYabC0UhH">What tablets from Smoking can be high blood pressure</a> - [x] <a href="http://ecojardin.pl/files/cardiovascular-disease-inheritance.xml">Cardiovascular Disease Presentation Class 9</a> - [x] <a href="https://hack.utopia-lab.org/s/0wd68I1GC">https://hack.utopia-lab.org/s/0wd68I1GC</a> <a href="https://pad.sra.uni-hannover.de/s/ROSbjskDzv">https://pad.sra.uni-hannover.de/s/ROSbjskDzv</a> <a href="https://hedgedoc.ggu.cz/s/cKhcNrEODm">https://hedgedoc.ggu.cz/s/cKhcNrEODm</a> <a href="https://hedgedoc.team23.org/s/Q57iwMEq1G">https://hedgedoc.team23.org/s/Q57iwMEq1G</a> <a href="https://md.coredump.ch/s/v6QJwXsqV">https://md.coredump.ch/s/v6QJwXsqV</a> <a href="https://md.rappet.xyz/s/26wMvIBjD3">https://md.rappet.xyz/s/26wMvIBjD3</a> <a href="https://pad.data.coop/s/E2hfx1kSb">https://pad.data.coop/s/E2hfx1kSb</a> <a href="https://pad.stuve.de/s/I9Kefl_tR">https://pad.stuve.de/s/I9Kefl_tR</a> <a href="https://hack.utopia-lab.org/s/PsS2Av3LR">https://hack.utopia-lab.org/s/PsS2Av3LR</a> <a href="https://doc.fung.uy/s/pj7Z2RWClA">https://doc.fung.uy/s/pj7Z2RWClA</a> <a href="https://md.giplt.nl/s/d_5aXyLbTz">https://md.giplt.nl/s/d_5aXyLbTz</a> <a href="https://md.sigma2.no/s/rV6u7f12V">https://md.sigma2.no/s/rV6u7f12V</a> <a href="https://doc.gnuragist.es/s/31pd6RsVWK">https://doc.gnuragist.es/s/31pd6RsVWK</a> <a href="https://pad.fablab-siegen.de/s/gfRnljAF09">https://pad.fablab-siegen.de/s/gfRnljAF09</a> <a href="https://hd.platypwnies.de/s/9KTeXuWDlg">https://hd.platypwnies.de/s/9KTeXuWDlg</a> <a href="https://pad.eisfunke.com/s/QkNY2goDus">https://pad.eisfunke.com/s/QkNY2goDus</a> <a href="https://hedgedoc.jcg.re/s/NHQvPySDvs">https://hedgedoc.jcg.re/s/NHQvPySDvs</a> <a href="https://doc.interscalar.eu/s/Cwiur1hpA">https://doc.interscalar.eu/s/Cwiur1hpA</a> <a href="https://pad.demokratie-dialog.de/s/NTd_5EguBE">https://pad.demokratie-dialog.de/s/NTd_5EguBE</a> <a href="https://pad.c3voc.de/s/q5oox1MFa">https://pad.c3voc.de/s/q5oox1MFa</a> <a href="https://pad.geolab.space/s/a4NXEHxkH">https://pad.geolab.space/s/a4NXEHxkH</a> <a href="https://hedgedoc.nrp-nautilus.io/s/BW4pyAdmt8">https://hedgedoc.nrp-nautilus.io/s/BW4pyAdmt8</a> <a href="https://pad.darmstadt.social/s/5wLATuABGS">https://pad.darmstadt.social/s/5wLATuABGS</a> <a href="https://hedgedoc.inqbus.de/s/KVPBEtfCV">https://hedgedoc.inqbus.de/s/KVPBEtfCV</a> <a href="https://omoffice.de/s/rydUh3oMMx">https://omoffice.de/s/rydUh3oMMx</a> <a href="https://pad.medialepfade.net/s/1jxYVoV-s">https://pad.medialepfade.net/s/1jxYVoV-s</a> <a href="https://pads.dgnum.eu/s/k6NXD-ZAEa">https://pads.dgnum.eu/s/k6NXD-ZAEa</a> <a href="https://pad.multiplace.org/s/H1TIh3oMGg">https://pad.multiplace.org/s/H1TIh3oMGg</a> <a href="https://pad.deckenpfronn.info/s/0Zn_Ib7CX">https://pad.deckenpfronn.info/s/0Zn_Ib7CX</a> <a href="https://hedge.grin.hu/s/bVaNY2OIvG">https://hedge.grin.hu/s/bVaNY2OIvG</a> <a href="https://md.cortext.net/s/30eNNbovc">https://md.cortext.net/s/30eNNbovc</a> <a href="https://hedgedoc.stusta.de/s/0efTY6S-0">https://hedgedoc.stusta.de/s/0efTY6S-0</a> <a href="https://pad.nantes.cloud/s/M33ufC17uv">https://pad.nantes.cloud/s/M33ufC17uv</a> <a href="https://hedgedoc.timon.ch/s/LuFaXb2Tk">https://hedgedoc.timon.ch/s/LuFaXb2Tk</a> <a href="https://md.chaosdorf.de/s/gpsoGs_4RQ">https://md.chaosdorf.de/s/gpsoGs_4RQ</a> <a href="https://pad.ccc-p.org/s/UEQpAqgK-J">https://pad.ccc-p.org/s/UEQpAqgK-J</a> <a href="https://md.softwarefreedom.net/s/ow8M2_4DW">https://md.softwarefreedom.net/s/ow8M2_4DW</a> <a href="https://hedgedoc.faimaison.net/s/OesGjpnQ4I">https://hedgedoc.faimaison.net/s/OesGjpnQ4I</a> <a href="https://text.fraction.jp/s/I9nLIhNtu">https://text.fraction.jp/s/I9nLIhNtu</a> <a href="https://md.infs.ch/s/Z5meuhmxOb">https://md.infs.ch/s/Z5meuhmxOb</a> <a href="https://editor.celtoi.org/s/bcr6WQ3gr">https://editor.celtoi.org/s/bcr6WQ3gr</a> <a href="https://dok.kompot.si/s/T8uRBM3fSJ">https://dok.kompot.si/s/T8uRBM3fSJ</a> <a href="https://write.frame.gargantext.org/s/SyO7q3szfl">https://write.frame.gargantext.org/s/SyO7q3szfl</a> <a href="https://pad.koeln.ccc.de/s/EVu-tGtF3">https://pad.koeln.ccc.de/s/EVu-tGtF3</a> <a href="https://md.studibla.ch/s/cY3Ahpp2Ku">https://md.studibla.ch/s/cY3Ahpp2Ku</a> <a href="https://doc.interscalar.eu/s/6HjBBrXIw">https://doc.interscalar.eu/s/6HjBBrXIw</a> <a href="https://markdown.iv.cs.uni-bonn.de/s/AWX4mtOXr">https://markdown.iv.cs.uni-bonn.de/s/AWX4mtOXr</a> <a href="https://doc.hkispace.com/s/YBvGf9s34">https://doc.hkispace.com/s/YBvGf9s34</a> <a href="https://doc.cisti.org/s/b_Vuh8djWb">https://doc.cisti.org/s/b_Vuh8djWb</a> <a href="https://pad.dominick-leppich.de/s/dJfi6Hsk1">https://pad.dominick-leppich.de/s/dJfi6Hsk1</a> <a href="https://notas.gaiacoop.tech/s/kBrZUNIPT">https://notas.gaiacoop.tech/s/kBrZUNIPT</a> <a href="https://notes.medien.rwth-aachen.de/s/VzidBa8jvD">https://notes.medien.rwth-aachen.de/s/VzidBa8jvD</a> <a href="https://n.jo-so.de/s/V0N17YaH1">https://n.jo-so.de/s/V0N17YaH1</a> <a href="https://hedgedoc.stura-ilmenau.de/s/ED79JDWkZs">https://hedgedoc.stura-ilmenau.de/s/ED79JDWkZs</a> <a href="https://md.globenet.org/s/y5v-qwhxu">https://md.globenet.org/s/y5v-qwhxu</a> <a href="https://pad.stuve.de/s/WXqdXN_g-">https://pad.stuve.de/s/WXqdXN_g-</a> <a href="https://doc.spiegie.de/s/KDP9tQTz6">https://doc.spiegie.de/s/KDP9tQTz6</a> <a href="https://hedgedoc.c3d2.de/s/oXEUd5NEvx">https://hedgedoc.c3d2.de/s/oXEUd5NEvx</a> <a href="https://hedgedoc.obermui.de/s/UJYjQQe3da">https://hedgedoc.obermui.de/s/UJYjQQe3da</a> <a href="https://md.eris.cc/s/VRb-qYBmE0">https://md.eris.cc/s/VRb-qYBmE0</a> <a href="https://pad.wolkenbar.de/s/_SBVT0r7VK">https://pad.wolkenbar.de/s/_SBVT0r7VK</a> <a href="https://md.gafert.org/s/Fqkt3xXLs">https://md.gafert.org/s/Fqkt3xXLs</a> <a href="https://notes.stuve.fau.de/s/d85F7SDFWy">https://notes.stuve.fau.de/s/d85F7SDFWy</a> <a href="https://notes.rabjerg.de/s/BJ5inhsGfg">https://notes.rabjerg.de/s/BJ5inhsGfg</a> <a href="https://hedge.amosamos.net/s/pOohaGWIB8">https://hedge.amosamos.net/s/pOohaGWIB8</a> <a href="https://pad.hxx.cz/s/oEjnEFBhT0">https://pad.hxx.cz/s/oEjnEFBhT0</a> <a href="https://notes.phys-el.ru/s/zWKYDApRr1">https://notes.phys-el.ru/s/zWKYDApRr1</a> <a href="https://docs.aix.inrae.fr/s/KF6fy_ImD">https://docs.aix.inrae.fr/s/KF6fy_ImD</a> <a href="https://hedgedoc.private.coffee/s/bWy32VhiW">https://hedgedoc.private.coffee/s/bWy32VhiW</a> <a href="https://hackmd.hub.yt/s/agc_-ZRBJ">https://hackmd.hub.yt/s/agc_-ZRBJ</a> <a href="https://pad.mytga.de/s/09tM7OAEy">https://pad.mytga.de/s/09tM7OAEy</a> <a href="https://pad.aleph.world/s/pidQr3Ip8">https://pad.aleph.world/s/pidQr3Ip8</a> <a href="https://pads.tobast.fr/s/UREvPSLoQx">https://pads.tobast.fr/s/UREvPSLoQx</a> <a href="https://docs.snowdrift.coop/s/OmV_0mYbH">https://docs.snowdrift.coop/s/OmV_0mYbH</a> <a href="https://md.coredump.ch/s/GtYi6iYjH">https://md.coredump.ch/s/GtYi6iYjH</a> ## Cardiovascular Disease Presentation Class 9 ## Become a health expert presentation on the topic of cardiovascular disease for 9. Class! You want to know how the heart works and what can happen if there are problems? In our exciting presentation for the 9. Class, you will explore the world of cardiovascular diseases! What to expect? Simple explanations: How does the heart and the circulatory really? Important diseases at a Glance: high blood pressure, heart attack, stroke &amp; co. Risk factors: What's bad for the heart? (Smoking, lack of exercise, unhealthy diet ...) Prevention: How can you protect your heart today? Interactive elements: quiz questions, easy experiments and discussions Tips for a heart-healthy life style work in everyday life Why is this important? Cardiovascular diseases are one of the most common causes of death worldwide, but many of them through the use of simple measures to prevent! With this presentation, you gain not only Knowledge for teaching, but also valuable tips for a healthy life. Date: 28.03.2026 Location: Online-Pharmacy Cardio Balance Duration: approx. 45-60 minutes Come on over and discover how you make your heart happy can! Your health begins today. ❤️ Wenngut